These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17718943)

  • 21. Impairment of ciprofloxacin absorption by calcium polycarbophil.
    Kato R; Ueno K; Imano H; Kawai M; Kuwahara S; Tsuchishita Y; Yonezawa E; Tanaka K
    J Clin Pharmacol; 2002 Jul; 42(7):806-11. PubMed ID: 12092748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioavailability of ciprofloxacin in patients with acute infectious diarrhoe.
    Beckebaum S; Bircher J; Gallenkamp H
    Eur J Clin Pharmacol; 1996; 50(6):511-2. PubMed ID: 8858281
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacokinetics of ciprofloxacin in normal rabbits and changes observed in induced dehydrated state.
    Bashir S; Jamshaid M; Ahmad B; Iqbal J
    Pak J Pharm Sci; 2008 Jul; 21(3):225-9. PubMed ID: 18614416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of fever on the pharmacokinetics of ciprofloxacin.
    Beovic B; Mrhar A; Karba R; Zupancic T; Grabnar I; Belic A; Marolt-Gomiscek M
    Int J Antimicrob Agents; 1999 Jan; 11(1):81-5. PubMed ID: 10075283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new twist on food and drug interactions.
    Mayo Clin Womens Healthsource; 2003 Feb; 7(2):3. PubMed ID: 12592204
    [No Abstract]   [Full Text] [Related]  

  • 26. [Is the switch of fluoroquinolones from intravenous to oral administration useful in an intensive care unit? Economical approach].
    Turc J; Eve O; Tran Van D; Wey PF; Martinez JY
    Ann Fr Anesth Reanim; 2009 Feb; 28(2):179-80. PubMed ID: 19171451
    [No Abstract]   [Full Text] [Related]  

  • 27. Ten years of ciprofloxacin: the past, present and future. Pharmacokinetics. Introduction.
    Wise R
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():41. PubMed ID: 10225570
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacokinetics of difloxacin in pigs and broilers following intravenous, intramuscular, and oral single-dose applications.
    Ding HZ; Yang GX; Huang XH; Chen ZL; Zeng ZL
    J Vet Pharmacol Ther; 2008 Jun; 31(3):200-4. PubMed ID: 18471140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ciprofloxacin prolonged-release tablets do not affect warfarin pharmacokinetics and pharmacodynamics.
    Washington C; Hou SY; Hughes NC; Campanella C; Berner B
    J Clin Pharmacol; 2007 Oct; 47(10):1320-6. PubMed ID: 17724088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Penetration of ciprofloxacin into the interstitial space of inflamed foot lesions in non-insulin-dependent diabetes mellitus patients.
    Müller M; Brunner M; Hollenstein U; Joukhadar C; Schmid R; Minar E; Ehringer H; Eichler HG
    Antimicrob Agents Chemother; 1999 Aug; 43(8):2056-8. PubMed ID: 10428936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of antibiotic levels in lung tissue with erosion-controlled dosage forms.
    Saïdna M; Ouriemchi EM; Vergnaud JM
    Eur J Drug Metab Pharmacokinet; 1997; 22(3):237-43. PubMed ID: 9358205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comment on "refractory hypoglycemia from ciprofloxacin and glyburide interaction".
    Roberge R
    Clin Toxicol (Phila); 2005; 43(3):213-4. PubMed ID: 15902799
    [No Abstract]   [Full Text] [Related]  

  • 33. A study of ciprofloxacin kinetics in human muscle and gut tissues.
    Viell B; Vestweber KH; Scholl H; Schaaf S
    J Chemother; 1989 Jul; 1(4 Suppl):575-6. PubMed ID: 16312539
    [No Abstract]   [Full Text] [Related]  

  • 34. Antimicrobial impregnation of cartilage implants with ciprofloxacin.
    Maier H; Zielinski D; Adler D
    J Chemother; 1989 Jul; 1(4 Suppl):554-5. PubMed ID: 16312529
    [No Abstract]   [Full Text] [Related]  

  • 35. Ophthalmic controlled release in situ gelling systems for ciprofloxacin based on polymeric carriers.
    Al-Kassas RS; El-Khatib MM
    Drug Deliv; 2009 Apr; 16(3):145-52. PubMed ID: 19514974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The administration of ciprofloxacin during continuous renal replacement therapy: pilot study.
    Hayakawa M; Fujita I; Iseki K; Gando S
    ASAIO J; 2009; 55(3):243-5. PubMed ID: 19318919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuing problem of ciprofloxacin administered with interacting drugs.
    Lomaestro BM; Lesar TS
    Am J Hosp Pharm; 1994 Mar; 51(6):832. PubMed ID: 8010328
    [No Abstract]   [Full Text] [Related]  

  • 38. Penetration of ciprofloxacin into the mucosa of the human maxillary sinus.
    Maier H; Zielinski D; Seigoleit A
    J Chemother; 1989 Jul; 1(4 Suppl):570-1. PubMed ID: 16312536
    [No Abstract]   [Full Text] [Related]  

  • 39. Concentration of ciprofloxacin and metronidazole in human tissues during abdominal surgery.
    Hopf G; Boecker R; Benz K; Stuetz G
    J Chemother; 1989 Jul; 1(4 Suppl):562-4. PubMed ID: 16312533
    [No Abstract]   [Full Text] [Related]  

  • 40. Population pharmacokinetics of enrofloxacin and its active metabolite ciprofloxacin in ill cows.
    Fu LX; Jiang ZG; Ding HZ; Liu YH
    J Vet Pharmacol Ther; 2008 Jun; 31(3):240-5. PubMed ID: 18471145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.